Long-term follow-up of 386 consecutive patients with essential thrombocythemia: Safety of cytoreductive therapy-Reference-Cited by-同舟云学术

Long-term follow-up of 386 consecutive patients with essential thrombocythemia: Safety of cytoreductive therapy

Published:2009-04 Issue:4 Volume:84 Page:215-220
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Palandri Francesca,Catani Lucia,Testoni Nicoletta,Ottaviani Emanuela,Polverelli Nicola,Fiacchini Mauro,De Vivo Antonio,Salmi Federica,Lucchesi Alessandro,Baccarani Michele,Vianelli Nicola

Publisher

Wiley

Subject

Hematology

Reference36 articles.

1. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel;Tefferi;Blood,2007

2. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia;Cortelazzo;J Clin Oncol,1990

3. The interaction between leukocytosis and other risk factors for thrombosis in essential thrombocythemia;Tefferi;Blood,2007

4. Risk factors for thrombosis and bleeding and their influence on therapeutic decisions in patients with essential thrombocythemia;Griesshammer;Semin Thromb Hemost,2006

5. Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with essential thrombocythemia;Radaelli;Hematol Oncol,2007

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of thrombosis in myeloproliferative neoplasia;HEMATOLOGIE;2024

2. Asymptomatic Essential Thrombocytosis Presenting with Extrahepatic Portal Vein Thrombosis: A Case Report;American Journal of Case Reports;2023-08-09

3. Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review;Biomedicines;2023-01-28

4. Clonal hematopoiesis and cardiovascular diseases: role of JAK2V617F;Journal of Cardiology;2023-01

5. Thrombosis and Myeloproliferative Neoplasms;Pathogenesis and Treatment of Leukemia;2023